Arcadia Biosciences, Inc. (NASDAQ:RKDA) Q1 2024 Earnings Call Transcript May 9, 2024
Arcadia Biosciences, Inc. beats earnings expectations. Reported EPS is $-1.78, expectations were $-2.52. RKDA isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here).
Operator: Thank you for standing by. My name is Parilla, and I will be your conference operator today. At this time, I would like to welcome everyone to the Arcadia Biosciences Q1 2024...
